Tag: BIT

Biotron ASX BIT Phase 2 trial results HIV drug BIT225 Conference on Retroviral and Opportunistic Infections CROI

Biotron presents further phase 2 trial results for HIV drug BIT225

Clinical stage company Biotron (ASX: BIT) is preparing to present results from its ongoing phase 2 trial into its lead BIT225 drug at the annual...
Read more
Biotron ASX BIT coronavirus test compounds

Biotron to commence testing of compounds to destroy coronavirus

Australian clinical stage company Biotron (ASX: BIT) has announced it will commence the evaluation of “several promising compounds” which could target various strains of...
Read more
Biotron ASX BIT Phase 2 clinical trial success HIV drug biotech shares

Biotron rides wave of Phase 2 clinical trial success for HIV drug

Biotechnology company Biotron (ASX: BIT) is enjoying its moment in the sun on the back of a skyrocketing share price since news of a...
Read more

RECENT POSTS

STOCK SUMMARY

INVESTOR TOOLS

FOLLOW US

HOT TOPICS

TRENDING POSTS

Small Caps ASX Australian stock market
Small Caps is Australia's #1 site for news & information on ASX listed small cap companies.

Small Caps and affiliated companies accept no responsibility for any claim, loss or damage as a result of information provided or its accuracy. The information provided on this site is general in nature, not financial product advice, see a financial expert before making any investment decision. Your personal objectives, financial situation or needs have not been taken into consideration. There may be a conflict of interest present with commercial arrangements with companies and/or stock held. Small Caps or an associate may receive a commission for funds raised.
Copyright 2020 Small Caps. All rights reserved.